Skip to content

Brain Olfactory Pathways in Prader-Willi Syndrome

Deciphering Brain Olfactory Pathways in Prader-Willi Syndrome

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07006207
Acronym
PRADOL
Enrollment
30
Registered
2025-06-05
Start date
2025-06-23
Completion date
2025-12-31
Last updated
2025-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prader-Willi Syndrome

Keywords

cerebral activity, Olfactory activation

Brief summary

Studying the cerebral activity of children with Prader-Willi Syndrom (PWS) when the study propose to them nasal activations.

Detailed description

The present study propose to implement fMRI and olfactory tests to describe olfactory brain activation and olfactory skills in early OT-exposed and non-exposed children with PWS. This study is part of a wider project in collaboration with the team of S. Steculorum at the Max Planck Institute in Germany who assess the architectural and molecular characterization of the olfactory system development in a mice model of PWS and the role of early OT treatment. Moreover, the study will take advantage of the MRI to document the long-term brain connectivity of early OT-exposed and non-exposed children.

Interventions

the patients have a sniff-test

OTHERfunctional MRI

patients have a an f MRI

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* child with a genetically confirmed diagnosis of PWS and for whom the genetic subtype (deletion or non deletion) has been identified * Child aged between 5 and 7 years * Child with a planned hospitalization at the Toulouse reference center for PWS

Exclusion criteria

* Presence of a contraindication to MRI * Allergy to any of the fragrances used in the olfactory test * Presence of an ENT infection such as rhinitis or sinusitis on the day of inclusion * Reported anosmia * Administrative problems.

Design outcomes

Primary

MeasureTime frameDescription
hyperactivation of the right amygdala in young children with PWS not early OT-exposed and aged between 5 and 7 years in response to a sweet food odor compared to a neutral non-food odor.day 1intensity of right amygdala in fMRI

Secondary

MeasureTime frameDescription
hyperactivation of the right amygdala in PWS children stimulated by a sweet food odor vs. a non-food odor compared to non-exposed children.day 1intensity of right amygdala in fMRI
composite outcome witn an association between olfactory fMRI results and eating behavior in early OT-exposed and non-exposed children with PWS.day 1scores of the eating beahaviour questionnaires
olfactory skills in early OT-exposed and non-exposed children with PWS.Day 1scores of the sniff test between OT-exposed and non-exposed children.
resting brain connectivity in early OT-exposed and non-exposed children with PWS.day 1brain connectivity in fMRI between OT-exposed and non-exposed children.

Countries

France

Contacts

Primary ContactJulie CORTADELLAS
cortadellas.j@chu-toulouse.fr0534557635
Backup ContactNadege ALGANS
algans.n@chu-toulouse.fr0561777204

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026